A detailed history of Cutler Group LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Cutler Group LP holds 300 shares of ARVN stock, worth $7,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 600 50.0%
Holding current value
$7,758
Previous $24,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$36.38 - $52.31 $10,914 - $15,693
-300 Reduced 50.0%
300 $12,000
Q4 2023

Jan 18, 2024

BUY
$14.19 - $42.33 $8,514 - $25,398
600 New
600 $24,000
Q4 2022

Feb 07, 2023

BUY
$32.47 - $57.24 $3,247 - $5,724
100 New
100 $3,000
Q1 2022

Apr 14, 2022

SELL
$60.27 - $81.57 $60,270 - $81,570
-1,000 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$65.85 - $96.21 $52,679 - $76,968
800 Added 400.0%
1,000 $82,000
Q3 2021

Oct 26, 2021

SELL
$73.2 - $107.87 $329,400 - $485,415
-4,500 Reduced 95.74%
200 $16,000
Q4 2020

Jan 21, 2021

SELL
$20.19 - $84.93 $38,361 - $161,367
-1,900 Reduced 28.79%
4,700 $399,000
Q3 2020

Oct 27, 2020

SELL
$22.99 - $36.34 $16,092 - $25,438
-700 Reduced 9.59%
6,600 $155,000
Q2 2020

Jul 22, 2020

BUY
$29.88 - $56.74 $68,724 - $130,502
2,300 Added 46.0%
7,300 $244,000
Q1 2020

May 07, 2020

BUY
$33.0 - $54.5 $161,700 - $267,050
4,900 Added 4900.0%
5,000 $201,000
Q4 2019

Feb 06, 2020

BUY
$15.39 - $44.38 $1,539 - $4,438
100 New
100 $4,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.